• Go to navigation
  • Go to content
Patient Health International

You are here

  • Home
  • AstraZeneca medicines
  • Faslodex® (fulvestrant)

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News & feature articles
  • Body map
  • List of health conditions
  • Esophageal varices
  • Interactive area
  • Interactive learning
  • About medicines
  • AstraZeneca medicines
  • About clinical trials
  • Glossary
  • Links
  • Sitemap

Faslodex® (fulvestrant)

Alternative brand (trade) names:

What is Faslodex® ?

Faslodex contains the medicine fulvestrant, which belongs to a group of medicines called anti-oestrogens without agonist activity. Faslodex down-regulates the oestrogen receptor.

What is Faslodex® used for?

Faslodex is used to treat locally advanced or metastatic, hormone receptor-positive breast cancer in postmenopausal women who have been previously treated with anti-oestrogen therapy.

How does Faslodex® work ?

  • Oestrogen is a female sex hormone (natural chemical produced by the body) that is known to be able to encourage the growth of some types of breast cancer cells.

  • Faslodex stops the action of oestrogen by preventing it from attaching itself (binding) to sites (called receptors) on cancer cells.

  • Faslodex also causes a decrease, or downregulation, in oestrogen receptor concentration and causes the receptors to change shape and become less functional; without functioning oestrogen receptors, oestrogen cannot signal the breast cancer cell to grow.

  • By stopping the actions of oestrogen, Faslodex is useful in slowing the growth of the tumour and may cause it to shrink.

How is Faslodex® given ?

Faslodex is supplied as a solution for intra-muscular injection.

Country specific information

To consult your local information.

Any medical information on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. Read more important information.

Back to search

  • Advanced search

Quick links

  • Investor information
  • Press information
  • AstraZeneca US

Page tools

  • Print
  • Bookmark this page

Related links

  • Other countries

List of conditions

AstraZeneca medicines

AstraZeneca International

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009